GP
GWPH

Girard Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Girard Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-175
Closed -$30K – 909
2018
Q3 		$30K Buy
+175
New +$25.2K 0.01% 533

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Girard Partners's GWPH Position: Q4 2018 in Review

Girard Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 175 shares — an estimated $30K sold.

Girard Partners first reported a position in GWPH in Q3 2018 and held it in 1 quarter. The position peaked at $30K in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • Girard Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Girard Partners sold 175 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $30K.
  • Girard Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 1 quarter.
  • Girard Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $30K in Q3 2018.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.